Cargando…
Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures
BACKGROUND: The real-world impact of breathing zone air purification and coronavirus disease 2019 (COVID-19) mitigation measures on healthcare-associated infections is not well documented. Engineering solutions to treat airborne transmission of disease may yield results in controlled test chambers o...
Autores principales: | Ereth, M.H., Fine, J., Stamatatos, F., Mathew, B., Hess, D., Simpser, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295046/ https://www.ncbi.nlm.nih.gov/pubmed/34302883 http://dx.doi.org/10.1016/j.jhin.2021.07.006 |
Ejemplares similares
-
Direct and indirect healthcare and carbon savings with ACTIVE Particle Control(TM) air-purification
por: Ereth, Mark, et al.
Publicado: (2023) -
Direct-Read Fluorescence-Based Measurements of Bioaerosol Exposure in Home Healthcare
por: Nathu, Vishal D., et al.
Publicado: (2022) -
Role of viral bioaerosols in nosocomial infections and measures for prevention and control
por: Bing-Yuan, et al.
Publicado: (2018) -
Airborne bioaerosols and their impact on human health
por: Kim, Ki-Hyun, et al.
Publicado: (2018) -
Bioaerosol sampling of a ventilated patient with COVID-19
por: Lane, Morgan A., et al.
Publicado: (2020)